Invacare 2009 Annual Report Download - page 110

Download and view the complete annual report

Please find page 110 of the 2009 Invacare annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 128

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128

INVACARE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Business Segments—Continued
2009 2008 2007
Earnings (loss) before income taxes
North America/HME ..................................... $ 36,237 $ 17,655 $ 1,766
Invacare Supply Group ................................... 5,374 2,192 3,198
Institutional Products Group ............................... 9,213 6,725 (227)
Europe ................................................ 34,685 44,675 43,321
Asia/Pacific ............................................ 1,639 8,705 1,532
All Other(1) ............................................ (39,869) (32,145) (38,004)
Consolidated ........................................... $ 47,279 $ 47,807 $ 11,586
Assets
North America/HME ..................................... $ 310,404 $ 359,364 $ 385,532
Invacare Supply Group ................................... 86,469 88,540 88,106
Institutional Products Group ............................... 45,518 33,491 44,806
Europe ................................................ 761,992 683,870 804,677
Asia/Pacific ............................................ 90,318 90,062 104,297
All Other(1) ............................................ 64,800 59,146 72,624
Consolidated ........................................... $1,359,501 $1,314,473 $1,500,042
Long-lived assets
North America/HME ..................................... $ 72,527 $ 99,709 $ 119,866
Invacare Supply Group ................................... 24,085 24,312 24,853
Institutional Products Group ............................... 31,191 28,103 34,880
Europe ................................................ 596,142 517,319 610,074
Asia/Pacific ............................................ 50,323 43,163 56,024
All Other(1) ............................................ 56,769 50,809 63,260
Consolidated ........................................... $ 831,037 $ 763,415 $ 908,957
Expenditures for assets
North America/HME ..................................... $ 8,110 $ 6,590 $ 7,138
Invacare Supply Group ................................... 196 506 148
Institutional Products Group ............................... 245 962 813
Europe ................................................ 5,268 6,311 7,669
Asia/Pacific ............................................ 3,433 5,567 4,272
All Other(1) ............................................ 747 21 28
Consolidated ........................................... $ 17,999 $ 19,957 $ 20,068
(1) Consists of un-allocated corporate selling, general and administrative costs and intercompany profits, which
do not meet the quantitative criteria for determining reportable segments. In addition, the “All other”
earnings (loss) before income taxes includes debt finance charges, interest and fees associated with debt
refinancing, the gain (loss) associated with a consolidated variable interest entity and impairment charges
recognized related to limited partnership investments.
FS-42